COVID-19

Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, Yuanyuan Zha, Apameh Pezeshk, Alexandra Cabanov, Athalia R Pyzer, Jonathan Trujillo, Benjamin A Derman, Peter O'Donnell, Andrzej Jakubowiak, Hedy L Kindler, Christine Bestvina, Thomas F Gajewski

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004766; DOI: 10.1136/jitc-2022-004766
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research
Marco Palla, Luigi Scarpato, Rossella Di Trolio, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004397; DOI: 10.1136/jitc-2021-004397
JAK inhibitors and COVID-19
Gabriel Levy, Paola Guglielmelli, Peter Langmuir, Stefan Constantinescu

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e002838; DOI: 10.1136/jitc-2021-002838
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study
Qi Mei, Guangyuan Hu, Yang Yang, Bo Liu, Junping Yin, Ming Li, Qiao Huang, Xi Tang, Alexander Böhner, Amy Bryant, Christian Kurts, Xianglin Yuan, Jian Li

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004157; DOI: 10.1136/jitc-2021-004157
Spontaneous tumor regression following COVID-19 vaccination
Luana Guimaraes de Sousa, Daniel J McGrail, Kaiyi Li, Mario L Marques-Piubelli, Cipriano Gonzalez, Hui Dai, Sammy Ferri-Borgogno, Myrna Godoy, Jared Burks, Shiaw-Yih Lin, Diana Bell, Renata Ferrarotto

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004371; DOI: 10.1136/jitc-2021-004371
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
Yifei Ma, Nianqi Liu, Youlong Wang, Jiling Zeng, Ying-Ying Hu, Wu Hao, Huazheng Shi, Pengfei Zhu, Jun Lv, Wei Fan, Xinjia Wang

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003712; DOI: 10.1136/jitc-2021-003712
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin Switzer, John Haanen, Paul C Lorigan, Igor Puzanov, Samra Turajlic

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002835; DOI: 10.1136/jitc-2021-002835
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D Goldman, Philip C Robinson, Thomas S Uldrick, Per Ljungman

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002630; DOI: 10.1136/jitc-2021-002630
Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy
Lorenzo Iovino, Laurel A Thur, Sacha Gnjatic, Aude Chapuis, Filippo Milano, Joshua A Hill

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002392; DOI: 10.1136/jitc-2021-002392
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
Muhammad Bilal Abid

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002307; DOI: 10.1136/jitc-2020-002307

Main menu

COVID-19

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COVID-19

Pages